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Abstract Using homology-based PCR, we have isolated cDNA
encoding a novel member (491 amino acids) of the angiopoietin
(Ang) family from human adult heart cDNA and have designated
it angiopoietin-3 (Ang3). The NH2-terminal and COOH-
terminal portions of Ang-3 contain the characteristic coiled-coil
domain and fibrinogen-like domain that are conserved in other
known Angs. Ang3 has a highly hydrophobic region at the N-
terminus (V21 amino acids) that is typical of a signal sequence
for protein secretion. Ang3 mRNA is most abundant in adrenal
gland, placenta, thyroid gland, heart and small intestine in
human adult tissues. Additionally, Ang3 is a secretory protein,
but is not a mitogen in endothelial cells.
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1. Introduction
The recent discovery of angiopoietin-1 (Ang1) and angio-
poietin-2 (Ang2) has provided insight into the molecular and
cellular mechanisms of blood vessel formation [1,2]. Ang1 and
Ang2 share about 60% amino acid identity and bind with
similar a⁄nity to the endothelial cell tyrosine kinase receptor,
Tie2 [1,2]. In vivo analysis by targeted gene inactivation re-
vealed that Ang1 recruited and sustained periendothelial sup-
port cells [3], while Ang2 disrupted blood vessel formation in
the developing embryo by antagonizing the e¡ects of Ang1 on
Tie2 [2]. Thus, Ang2 is a naturally occurring antagonist of
Ang1 that competes for binding to Tie2 and blocks Ang1-
induced Tie2 autophosphorylation [2]. However, ligands for
Tie1, Tie2-related receptor, have not been identi¢ed.
Ang1 and Ang2 have a characteristic protein structure that
contains a coiled-coil domain in the NH2-terminal portion
and a ¢brinogen-like domain in the COOH-terminal portion
[1,2]. Using homology-based PCR, we isolated cDNA encod-
ing a novel member of the angiopoietin (Ang) family and have
designated it angiopoietin-3 (Ang3). Our results demonstrate
that Ang3 is a secretory protein and may be a ligand to the
Tie1 or Tie2 receptor.
2. Materials and methods
2.1. Isolation of mouse and human Ang3
The partial cDNA of human Ang3 was ampli¢ed from the human
adult hearts cDNA as a template by PCR for 30 cycles at an anneal-
ing temperature of 52‡C using sense and antisense degenerate primers
representing all possible codons corresponding to the amino acid se-
quences of human Ang1 and Ang2, GEYWLG and SNLNGM, re-
spectively [1,2]. DNA of the expected size (V300 bp) was ampli¢ed.
The ampli¢ed DNA was sequenced by cycle sequencing using Ampli-
Cycle sequencing kit (Perkin Elmer). The novel ampli¢ed DNA was
cloned into the pCR-Blunt vector (Invitrogen). To determine the en-
tire coding region, the human adult heart cDNA was analyzed by the
rapid ampli¢cation of cDNA ends (RACE) method (Clontech).
2.2. Northern blot analysis
32P-labeled human Ang3 cDNA probe (nucleotides 1^714) was ra-
dio-labeled by the random priming method (Prime-a-Gene, Promega).
Hybridizations were performed in human multiple tissue Northern
blots (Clontech) according to the manufacturer’s instructions.
2.3. Expression of Ang3 cDNA in NRK293 cells and detection of
recombinant Ang3 protein by Western blotting analysis
Human Ang3 cDNA was inserted into CMV promoter driven
mammalian cell expression vector, pcDNA3.1/Myc-His (Invitrogen),
that has a DNA fragment (63 bp) encoding c-myc (EQKLISEEDL)
and a 6UHis tag (HHHHHH) at the 3P-terminus of coding region as
an open reading frame (CMV-Ang3-M-H). The CMV-Ang3-M-H
gene construct was transfected into NRK293 cells using Lipofect-
amine Plus (Gibco BRL) and incubated at 37. 5‡C for 48 h in Dul-
becco’s Modi¢ed Eagle’s Media with 2% fetal bovine serum under 5%
CO2-95% atmosphere. The culture supernatant and cell lysates of
NRK293 cells transfected with the CMV-Ang3-M-H were puri¢ed
by Ni-NTA Spin Column (Qiagen) and were separated by sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis system,
and the proteins were electro-transferred to nitrocellulose membranes
[4]. The nitrocellulose membranes were blocked by incubation in
blocking bu¡er, incubated with anti-myc or anti-His antibody,
washed, incubated with horseradish peroxidase conjugated secondary
antibody, and signals were visualized by the ECL detection method
according to the manufacturer’s protocol (Amersham).
2.4. Mitogenic assay for Ang3 in endothelial cells
The human Ang3 cDNA and human VEGF165 were inserted into
the CMV promoter-driven mammalian cell expression vector,
pcDNA3.1 (Invitrogen). The CMV-Ang3, CMV-VEGF165 or
pcDNA3.1 (mock) gene construct was transfected into NRK293 cells
using Lipofectamine Plus (Gibco BRL). The cells were incubated at
37.5‡C for 24 h in Dulbecco’s modi¢ed Eagle’s medium with 2% fetal
bovine serum under 5% CO2-95% atmosphere. Twenty-four hours
after transfection, conditioned medium was collected from NRK293
cells. Mitogenic assays for Ang3 or VEGF165 in human umbilical vein
endothelial cells (HUVECs) were performed as previously described
[5]. HUVECs between second and third passage were plated onto
gelatinized 24-well plates (2U104 cells per well) in M-199 medium
supplemented with 20% (v/v) fetal bovine serum and incubated for
24 h. Conditioned medium was diluted 10 times with the growth
medium and cells were stimulated for 48 h. Fresh conditioned medium
containing [3H]thymidine (Amersham; 1 WCi/well) was added to the
FEBS 21485 1-2-99
0014-5793/99/$19.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 0 0 0 8 - 3
*Corresponding author. Fax: (82) (652) 270-4071.
E-mail: gykoh@moak.chonbuk.ac.kr
Abbreviations: PCR, polymerase chain reaction; CMV, cytomegalo-
virus; cDNA, complementary deoxyribonucleic acid
FEBS 21485 FEBS Letters 443 (1999) 353^356
cells and stimulation was continued for another 24 h. Cells were
washed with PBS and were lysed with 0.5 N sodium hydroxide, and
incorporated radioactivity was determined by liquid scintillation
counting. Each experiment was performed in triplicate.
3. Results and discussion
3.1. Cloning and analysis of human Ang3
Ang1 and Ang2 have characteristic protein structures that
contain a coiled-coil domain in the NH2-terminal portion and
a ¢brinogen-like domain in the COOH-terminal portion [1,2].
Using degenerative primers corresponding to the conserved
amino acid sequences in ¢brinogen-like domain, GEYWLG
(Ang1, amino acids 353^358; Ang2, amino acids 351^356)
and SNLNGM (Ang1, amino acids 455^460; Ang2, amino
acids 453^458), a cDNA fragment encoding a novel Ang-re-
lated peptide was isolated from human adult heart cDNA.
The nucleotide sequence of the entire coding region was ob-
tained by the RACE method [6] using the human adult heart
adapter-ligated cDNA as a template (accession number at
GenBank nucleotide sequence database: AF107253). The nu-
cleotide sequence of the coding region allowed elucidation of
the complete amino acid sequence of a novel Ang (491 amino
acids). We designated this human protein Ang3. Alignment of
the deduced amino acid sequence of human Ang3 with those
for Ang1 and Ang2 is shown in Fig. 1. This polypeptide was
clearly a member of the angiopoietin family because the N-
terminal and C-terminal portions of Ang3 contained the char-
acteristic coiled-coil domain and ¢brinogen-like domain that
are found in other known Angs [1,2]. Five of the nine cys-
teines in Ang1 are conserved in Ang3 [1]. When gaps intro-
duced into the amino acid sequences for the purpose of align-
ment are ignored for calculations, human Ang3 is 29%
identical to human Ang1, and 26% identical to human
Ang2. In the ¢brinogen-like domains, the amino acid se-
quence of human Ang2 is 43% identical to human Ang1,
and 41% identical to human Ang2, indicating that Ang3 is a
novel angiopoietin family protein.
3.2. Expression of Ang3 mRNA in human adult tissues
The size of the main transcript was 3.0 kb, and a less abun-
dant transcript of 4.0 kb was present in most of the human
adult tissues where Ang3 mRNA was detected (Fig. 2). While
both sizes of Ang3 mRNA transcripts were abundant in adre-
nal gland, placenta, thyroid gland, heart, skeletal muscle, and
small intestine, they were less abundant in testis, ovary, colon,
pancreas, kidney, and stomach. Thus, Ang3 mRNA is widely
expressed in adult tissues and is expressed abundantly in
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Fig. 1. Comparison of human Ang3 with other members of the Ang
family. Alignment of the deduced amino acid sequences of human
Ang3, human Ang1 [1], and human Ang2 [2] is shown. Residues
that match the sequence of human Ang3 are shadowed. The aster-
isks above the human Ang3 sequence denote ¢ve cysteine residues
that are conserved in other angiopoietin family members. The line
below the human Ang3 sequence denotes a putative signal sequence
for protein secretion [9]. The arrows delimit the coiled-coil and ¢bri-
nogen-like domains.
Fig. 2. Northern blot analyses for detection of Ang3 mRNA in human adult tissues. Each lane contains approximately 2 Wg of puri¢ed poly-
adenylated RNA. Hybridization was performed with a 32P-labeled human Ang3 probe. The sizes of RNA molecular size makers, in kb, for the
Ang3 hybridization are shown to the right. Lanes H, B, Pl, Lu, Li, S, K, Pa, Sp, Th, Pr, T, O, Si, C, Pc, St, Tr, Sc, Ln, Tr, Ag and Bm indi-
cate RNA from the adult heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small in-
testine, colon, peripheral blood leukocyte, stomach, thyroid, spinal cord, lymph node, trachea, adrenal gland and bone marrow.
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highly vascularized adult tissues while Ang1 and Ang2
mRNAs are expressed in limited adult tissues [2]. These ¢nd-
ings suggest that Ang3 is required for maintenance of the
di¡erentiated state of endothelial cells in most adult tissues
[7,8].
3.3. Ang3 is a secreted protein but not an endothelial cell
mitogen
The amino acid sequence of human Ang3 has a highly
hydrophobic region at the N-terminus (V21 amino acids)
that is typical of a signal sequence for protein secretion
(Fig. 2). The signal sequence cleavage site was predicted to
lie between amino acid positions 21 (C) and 22 (R) by the
method of von Heijne [9]. Analysis and comparison of hydro-
phobicity pro¢les among Ang1, Ang2 and Ang3 were per-
formed according to Kyte and Doolittle [10]. These results
indicate that Ang3, like Ang1 and Ang2, mainly consists of
hydrophilic amino acids (Fig. 3). To demonstrate that Ang3 is
a secreted protein, NRK 293 cells were transfected with CMV
promoter-driven mammalian cell expression vector containing
human Ang3 cDNA with the 3P-terminal extension encoding
c-myc and 6UHis tags. To detect the Ang3 protein, both the
culture supernatant and cell lysate were examined by Western
blot analysis with anti-His tag antibody. A major band of
V66 kDa was detected in the culture supernatant, but not
in the cell lysate (Fig. 4). The observed molecular mass of the
major band was larger than the calculated molecular mass of
recombinant Ang3 (V57 kDa). The amino acid sequence of
Ang3 contained several potential glycosylation sites suggesting
that the observed larger size of Ang3 may be produced as a
glycoprotein. These results also indicate that human Ang3 is
an e⁄ciently secreted glycoprotein. Ang1 and Ang2 are both
secreted glycoproteins with considerable sequence homology
[1,2]. Both bind to the Tie2 receptor with similar a⁄nity, but
neither binds to the related receptor Tie1 [1,2]. Tie1 is remark-
ably similar in structure to Tie2 [11] and appears to control
another aspect of vessel integrity. Knockout mice lacking Tie1
die between embryonic day 14.5 and birth of edema and hem-
orrhage, implicating that Tie1 controls £uid exchange across
capillaries and hemodynamic stress resistance [12,13]. How-
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Fig. 3. The hydrophobicity pro¢les of human Ang3, Ang1 and
Ang2. The pro¢les were generated according to Kyte and Doolittle
[10] using a window of 10 residues.
Fig. 4. Detection of human Ang3 protein from the culture medium
and cell lysates of NRK 293 cells transfected with the CMV pro-
moter-driven mammalian cell expression vector containing the hu-
man Ang3 cDNA with the 3P-terminal extension encoding c-myc
and 6UHis tags. The culture medium and cell extracts of the trans-
fected NRK 293 cells were separated by SDS-polyacrylamide gel
(10%) electrophoresis. Human Ang3 protein was detected by West-
ern blotting analysis with anti-myc antibody (Invitrogen). CM, cul-
ture medium; CL, cell lysates. Rainbow molecular marker (Amer-
sham) was used to estimate molecular mass.
Fig. 5. The e¡ect of Ang3 on [3H]thymidine incorporation into en-
dothelial cells. Conditioned medium from NRK 293 cells transfected
with empty vector (mock) or expression vectors for VEGF165 or
Ang3 were diluted in growth medium, applied to HUVECs, and in-
corporation of [3H]thymidine was measured. The detailed procedure
is described in Section 2. The columns show the fold induction of
[3H]thymidine incorporation compared with basal activity induced
by conditioned medium from mock-transfected cells. The bars show
the mean þ S.D. of six independent experiments. Statistical analysis
between the values of mock and the values of VEGF165 or Ang3
were performed using Student’s t-test (*P6 0.05).
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ever, ligands for Tie1 have not been identi¢ed. Ang3 is a
possible ligand for Tie1 receptor.
The inability of Ang1 to stimulate endothelial cell prolifer-
ation was demonstrated [1]. We examined the ability of Ang3
to stimulate endothelial cell proliferation by analyzing the
incorporation of [3H]thymidine into HUVECs (Fig. 5). Con-
ditioned medium from transfected NRK 293 cells expressing
Ang3 did not alter in [3H]thymidine incorporation into DNA
of HUVECs, but in the positive controls, using conditioned
medium from transfected NRK 293 cells expressing VEGF165,
incorporation increased approximately 1.7-fold. These results
demonstrate that Ang3, like Ang1, is not an endothelial cell
growth factor in vitro. Thus, Ang3, like Ang1, may have a
vasculogenic e¡ect rather than an angiogenic e¡ect. Recent
studies [14,15] indicate that transgenic overexpression of
Ang1 or gene transfer of Ang1 increases vascularization in
vivo.
In summary, using homology-based PCR, we have isolated
cDNA encoding a novel member of the angiopoietin family
and have designated it Ang3. The NH2-terminal and COOH-
terminal portions of Ang3 contain the characteristic coiled-
coil domain and ¢brinogen-like domain that are conserved
in other known Angs. Ang3 mRNA is expressed in most
tissues and is expressed abundantly in highly vascularized
adult tissues. Ang3 is a secretory protein, but is not a mitogen
in endothelial cells. Whether Ang3 binds to the known Tie1 or
Tie2 receptor tyrosine kinases or to a novel and yet unidenti-
¢ed angiopoietin-3 receptor tyrosine kinase remains to be elu-
cidated.
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